Current Issue

Clinical Genitourinary Cancer

October 2022Volume 20Issue 5

Current Issue Links

• Articles in Press
• Past Issues

Submit Mobile

• Submit article

Explore

• Subscribe
• Editorial Board
• Elsevier's Oncology Journal Network
   
• Researcher Academy
   

Publish

• Submit Article
   
• Aims and Scope
• For Authors
• Supports Open Access
   

Connect

• Alerts
• Activate Online Access
   
• Career Opportunities
   
• CLCC
   
• CLML
   

Articles in Press

• 
  Original Study

  Real world data of diagnosis, survival, and treatment outcomes in patients with metastatic non clear cell renal cell carcinoma

  Izarn et al.

  Published online: September 24, 2022
• 
  Original Study

  Total Prostate Specific Antigen in Prostate Cancer Screening in Hyperglycemic Individuals

  Satir et al.

  Published online: September 23, 2022
• 
  Full length article

  Demographic profiles and survival outcomes of patients with urachal adenocarcinoma: a rare tumor of the urachal remnant

  Bhargava et al.

  Published online: September 23, 2022
• 
  Original Study OSA

  Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer

  Thomas et al.

  Published online: September 14, 2022

View All

Issue Highlights

• 

  Original Study

  Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder

  Marina Kosiba, L. Franziska Stolzenbach, Claudia Collà Ruvolo, Luigi Nocera, Mila Mansour, Zhe Tian, Frederik C. Roos, Andreas Becker, Luis A. Kluth, Derya Tilki, Shahrokh F. Shariat, Fred Saad, Felix K.H. Chun, Pierre I. Karakiewicz

• 

  Original Study

  Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma

  Makito Miyake, Takuto Shimizu, Nobutaka Nishimura, Keisuke Kiba, Fumisato Maesaka, Yuki Oda, Akira Tachibana, Mitsuru Tomizawa, Chihiro Ohmori, Yoshiaki Matsumura, Kazuki Ichikawa, Shinichiro Mizobuchi, Takanosuke Yoshikawa, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Satoshi Anai, Kazumasa Torimoto, Katsuya Aoki, Nobumichi Tanaka, Kiyohide Fujimoto on behalf of the Nara Urological Research and Treatment Group

• 

  Review

  Impact of New Systemic Therapies in Overall Survival in Non-Metastatic Castration Resistant Prostate Cancer: Systematic Review and Meta-Analysis

  Alejo Rodriguez-Vida, Andrés Rodríguez-Alonso, Eduardo Useros-Rodríguez, Fernando Lopez-Campos, Oscar Amor-Carro, Alberto Arribas-Ruiz, Javier Martinez-Torres, Javier Roca-Pardiñas, Alba Quesada-García, Jacobo R. Muñoz-Del-Toro, Álvaro Juárez-Soto

• 

  Original Study

  Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on Perioperative Outcomes and Health Care Costs

  Francesco Del Giudice, Stefanie van Uem, Shufeng Li, Fernandino L. Vilson, Alessandro Sciarra, Stefano Salciccia, Gian Maria Busetto, Martina Maggi, Letizia Tiberia, Pietro Viscuso, Vittorio Canale, Valeria Panebianco, Martina Pecoraro, Matteo Ferro, Marco Moschini, Wojciech Krajewski, David D'Andrea, Giovanni E. Cacciamani, Andrea Mari, Francesco Soria, Francesco Porpiglia, Cristian Fiori, Daniele Amparore, Enrico Checcucci, Riccardo Autorino, Ettore De Berardinis, Benjamin I. Chung

About

Clinical Genitourinary Cancer

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

more

Companion Journals

Metrics

Metrics

##

Impact Factor

##

5-Year Impact Factor

5.0

CiteScore

• More Journal Metrics
   
• Submit a Manuscript
   
• Top Social Media Articles
   

Co-Editors-in-Chief

Leonard Appleman, MD, Pittsburgh, Pennsylvania, United States of America

Matthew Milowsky, Chapel Hill, North Carolina, United States of America

 

Attention Qualified Recipients

If you are a qualified recipient of the US print edition of Clinical Genitourinary Cancer, click here to access the online edition.

Most Read (Last 30 Days)

• 
  Original Study

  Open Access

  CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

  Navani et al.

  Published online: July 20, 2022
• 
  Original Study

  Open Access

  Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States

  George et al.

  Published online: January 7, 2020
• 
  Original Study

  Impact of Body Mass Index on Outcomes in an Asian population of Advanced Renal Cell Carcinoma and Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors

  Ishihara et al.

  Published online: August 5, 2022
• 
  Original Study

  Open Access

  Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma

  Lyou et al.

  Published online: October 12, 2021
• 
  Review

  Open Access

  Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer

  Zhang et al.

  Published online: September 26, 2019
• 
  Original study

  Zonal NePhRO Scoring System: A Superior Renal Tumor Complexity Classification Model

  Hakky et al.

  Published online: October 10, 2013

Most Cited (Previous 3 Years)